Biopsy results after real-time ultrasound-guided transperineal implants for stage T1-T2 prostate cancer

Journal of Endourology

Volumn 14, Issue 4, 2000, Pages 375-380

  Stone, Nelson N ^a,b   Stock, Richard G ^a   Unger, Pamela ^a   Kao, Johnny ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125; PALLADIUM; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CONTROL; CANCER STAGING; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REAL TIME ECHOGRAPHY; SCORING SYSTEM; TREATMENT OUTCOME;

EID: 0033938350     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2000.14.375     Document Type: Article

References (40)

1. Stone NN, Ramin SA, Wesson MF, Stock R, Unger P, Klein G. Laparoscopic pelvic lymph node dissection combined with real time interactive transrectal guided transperineal radioactive seek implantation of the prostate. J Urol 1995;153:1555-1560.
2. Stock RG, Stone NN, DeWyngaert JK, Lavagnini P, Unger PD. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma. Cancer 1996;77:2386-2392.
3. 125I prostate implantation. Int J Radiat Oncol Biol Phys 1997;37:559-563.
4. Dattoli MJ, Wallner KE, Cash JC, Ross RE, Kovan JM, Sorace RA. Palladium-103 brachytherapy for clinical T1/T2 prostate carcinomas. Int J Radiat Oncol Bid Phys 1997;39:220.
5. Blasko JC, Ragde H, Luse RW, et al. Should brachytherapy be considered a therapeutic option in localized prostate cancer? Urol Clin North Am 1996;23:633-650.
6. 125iodine implantation for stage T1/T2 prostatic carcinoma. J Urol 1995; 154:1096-1099.
7. Sharkey J, Chovnick SD, Behar RJ, et al. Outpatient ultrasound-guided palladium 103 brachytherapy for localized adenocarcinoma of the prostate: A preliminary report of 434 patients. Urology 1998;51:796-803.
8. Stokes SH, Real JD, Adams PW, Clements JC, Wuertzer BS, Kan W. Transperineal ultrasound-guided radioactive seed implantation for organ-confined carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1997;37:337-341.
9. Wallner K, Roy J, Harrison L. Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma. J Clin Oncol 1996;14:449-453.
10. Ragde H, Abdel-Aziz AE, Snow PB, et al. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachy-therapy with or without 45-Gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma. Cancer 1998;83:989-1001.
11. Cox JD, Stoffel TJ. The significance of needle biopsy after irradiation for stage C adenocarcinoma of the prostate. Cancer 1977;40:156-160.
12. Freiha FS, Bagshaw MA. Carcinoma of the prostate: Results of post-irradiation biopsy. Prostate 1984;5:19-25.
13. Kabalin JN, Hodge KK, McNeal JE, Freiha FS, Stamey TA. Identification of residual cancer in the prostate following radiation therapy: Role of transrectal ultrasound guided biopsy and prostate specific antigen. J Urol 1989;142:326-331.
14. Kagan AR, Gordon J, Cooper JF, Nussbaum H, Chan P. A clinical appraisal of post-irradiation biopsy in prostate cancer. Cancer 1977;39:637-641.
15. Kaplan I, Prestidge BR, Cox RS, Bagshaw MA. Prostate specific antigen after irradiation for prostate carcinoma. J Urol 1990;144: 1172-1176.
16. Rhamy RK, Wilson SK, Caldwell WL: Biopsy-proved tumor following definitive irradiation for respectable carcinoma of the prostate. J Urol 1972;107:627-630.
17. Scardino PT, Frankel JM, Wheeler TM. Local control of prostate cancer with radiotherapy: Frequency and prognostic significance of positive results of post-irradiation prostate biopsy. Natl Cancer Inst Monogr 1988;7:95-101.
18. Laverdiere J, Gomez JL, Cusan L, et al. Beneficial effect of combination therapy administered prior and following external beam radiation therapy in localized prostate cancer. Int J Radiat Oncol Biol Phys 1997;37:247-252.
19. Kuban DA, El-Mahdi AM, Schellhammer PF. I-125 interstitial implantation for prostate cancer: What have we learned 10 years later? Cancer 1989;63:2415-2420.
20. Zelefsky MJ, Whitmore WF. Long-term results of retropubic permanent I-125 implantation of the prostate for clinically localized prostatic cancer. J Urol 1997;158:23-30.
21. Lee F, Torp-Pedersen ST, Meiselman L, et al. Transrectal ultrasound in the diagnosis and staging of local disease after I-125 seed implantation for prostate cancer. Int J Radiat Oncol Biol Phys 1988;15:1453-1459.
22. Stone NN, Stock RG, Unger P. Indications for seminal vesicle biopsy and laparoscopic pelvic lymph node dissection in men with localized carcinoma of the prostate. J Urol 1995;154:1392.
23. Stock RG, Stone NN, Ianuzzi C, Unger P. Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: Implications for patient selection in the radiotherapeutic management of prostate cancer. Int J Radiat Oncol Biol Phys 1995;33:815-821.
24. Stone NN, Stock RG. Brachytherapy for prostate cancer: Real time three dimensional interactive seed implantation. Techn Urol 1995;1:72-80.
25. Terk MD, Stock RG, Stone NN. Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol 1998;160:1379-1382.
26. Kuban DA, El-Mahdi AM, Schellhammer P. The significance of post-irradiation prostate biopsy with long-term follow-up. Int J Radiat Oncol Biol Phys 1992;24:409-414.
27. Crook J, Perry G, Robertson S, Esche B. Radiotherapy for localized prostate cancer: Assessment of results by systematic biopsy and PSA. Can J Urol 1996;3:195-201.
28. Prestidge BR, Kaplan I, Cox RS, Bagshaw MA. The clinical significance of a positive post-irradiation prostatic biopsy without metastases. Int J Radiat Oncol Biol Phys 1992;24:430-408.
29. Prestidge BR, Hoak DC, Grimm PD, Ragde H, Cavanagh W, Blasko JC. Posttreatment biopsy results following interstitial brachytherapy in early-stage prostate cancer. Int J Radiat Oncol Biol Phys 1997;37:31-39.
30. 125iodine implantation for localized prostate cancer using percutaneous approach. J Urol 1995;153:1020-1025.
31. Stock RG, Stone NN. The effect of prognostic factors on therapeutic outcome following transperineal prostate brachytherapy. Semin Surg Oncol 1997;13:454-460.
32. Stone NN, Stock RG. Prostate brachytherapy: Treatment strategies. J Urol 1999;162:421-426.
33. Keisling VJ, McAninch JW, Goebel JL, Agee RE. External beam radiotherapy for adenocarcinoma of the prostate: A clinical followup. J Urol 1980;124:851-854.
34. Freiha FS, Bagshaw MC. Carcinoma of the prostate: Results of post-irradiation biopsy. Prostate 1984;5:19-25.
35. Scardino PT, Wheeler TM. Local control of prostate cancer with radiotherapy: Frequency and prognostic significance of positive results of postirradiation prostate biopsy. Natl Cancer Inst Monogr 1988;7:95-103.
36. Schellhammer PF, El-Mahdi AM, Higgins EM, Schultheiss TE, Ladage LE, Babb TJ. Prostate biopsy after definitive treatment by interstitial 125 iodine implant or external beam radiation therapy. J Urol 1989;137:897-901.
37. Kabalin JN, Hodge KK, McNeal JE, Freiha FS, Stamey TA. Identification of residual cancer in the prostate following radiation therapy: Role of transrectal ultrasound guided biopsy and prostate specific antigen. J Urol 1989;142:326-331.
38. Pilepich MV, Sause WT, Shipley WU, et al. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: A randomized comparative trial of the Radiation Therapy Oncology Group. Urology 1995;45: 616-623.
39. Bolla M, Gonzalez D, Padraig W, et al. Improved survival in patients with clinically advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 1997;337:295-300.
40. Zeitlin SI, Sherman J, Raboy A, Lederman G, Albert P. High dose combination radiotherapy for the treatment of localized prostate cancer. J Urol 1998;160:91-96.